Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Total Non-Current Liabilities (2017 - 2025)

Catheter Precision (VTAK) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $7.0 million as the latest value for Q2 2025.

  • Quarterly Total Non-Current Liabilities rose 106.24% to $7.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Jun 2025, up 106.24% year-over-year, with the annual reading at $2.6 million for FY2023, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q2 2025 was $7.0 million at Catheter Precision, up from $6.5 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $11.7 million in Q2 2023, with the low at $2.4 million in Q1 2024.
  • Average Total Non-Current Liabilities over 3 years is $6.1 million, with a median of $5.3 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities crashed 71.21% in 2024, then soared 167.05% in 2025.
  • Over 3 years, Total Non-Current Liabilities stood at $2.6 million in 2023, then soared by 60.45% to $4.1 million in 2024, then skyrocketed by 69.12% to $7.0 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $7.0 million, $6.5 million, and $4.1 million for Q2 2025, Q1 2025, and Q3 2024 respectively.